These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 3527493)
21. [Cholera in Benin (epidemic of 1991)]. Foundohou J; Josse R; Anagonou S; Comlanvi E; Mevel A; Catraye J; Izurietta H; Gbaguidi E; Diallo S; Dodin A Med Trop (Mars); 1993; 53(3):341-9. PubMed ID: 8289628 [TBL] [Abstract][Full Text] [Related]
22. Bacterial-associated cholera toxin and GM1 binding are required for transcytosis of classical biotype Vibrio cholerae through an in vitro M cell model system. Blanco LP; DiRita VJ Cell Microbiol; 2006 Jun; 8(6):982-98. PubMed ID: 16681839 [TBL] [Abstract][Full Text] [Related]
26. Experimental immunisation and protection of guinea pigs with Vibrio cholerae toxoid and mucinases, neuraminidase and proteinase. Stewart-Tull DE; Lucas C; Bleakley CR Vaccine; 2004 Jun; 22(17-18):2137-45. PubMed ID: 15149770 [TBL] [Abstract][Full Text] [Related]
27. [Cholera in Fribourg. Apropos a case]. Nicole A; Sarasin F; Gaschen M; Regamey C Schweiz Med Wochenschr; 1986 Jun; 116(25):856-8. PubMed ID: 3738456 [TBL] [Abstract][Full Text] [Related]
28. Oral vaccines for cholera control. Chaturvedi S; Chaturvedi S Natl Med J India; 1997; 10(1):17-8. PubMed ID: 9069701 [TBL] [Abstract][Full Text] [Related]
29. Statement on new oral cholera and travellers' diarrhea vaccination. ; Can Commun Dis Rep; 2005 Jul; 31(ACS-7):1-11. PubMed ID: 15999424 [No Abstract] [Full Text] [Related]
30. A review of the current status of enteric vaccines. Levine MM; Noriega F P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876 [TBL] [Abstract][Full Text] [Related]
31. [Physiopathology of diarrhea in cholera]. Thomas J; Josserand C; André LJ Arch Fr Mal App Dig; 1974 Jun; 63(4):327-41. PubMed ID: 4376678 [No Abstract] [Full Text] [Related]
32. Outbreaks of cholera in Nepal. Pokhrel BM; Kubo T Southeast Asian J Trop Med Public Health; 1996 Sep; 27(3):574-9. PubMed ID: 9185273 [TBL] [Abstract][Full Text] [Related]
33. Activation and suppression of the proinflammatory immune response by Vibrio cholerae toxins. Satchell KJ Microbes Infect; 2003 Nov; 5(13):1241-7. PubMed ID: 14623020 [TBL] [Abstract][Full Text] [Related]
35. [Utilization of new findings about cholera toxin for prevention and therapy]. Holý J Cas Lek Cesk; 1982 Apr; 121(15):475. PubMed ID: 7083294 [No Abstract] [Full Text] [Related]
37. Breast milk reduces the risk of illness in children of mothers with cholera: observations from an epidemic of cholera in Guinea-Bissau. Qureshi K; Mølbak K; Sandström A; Kofoed PE; Rodrigues A; Dias F; Aaby P; Svennerholm AM Pediatr Infect Dis J; 2006 Dec; 25(12):1163-6. PubMed ID: 17133163 [TBL] [Abstract][Full Text] [Related]
38. Recent advances in cholera pathophysiology and therapeutics. Nalin DR Prog Drug Res; 1975; 19():563-9. PubMed ID: 769073 [No Abstract] [Full Text] [Related]
39. [2 Dutch travelers returning from Thailand with cholera]. Smit AA; Kuijper EJ; Schultz MJ; Wieling W; Speelman P Ned Tijdschr Geneeskd; 1994 Apr; 138(17):871-3. PubMed ID: 8183399 [TBL] [Abstract][Full Text] [Related]
40. [Cholera---the tip of an iceberg]. Ostberg S Lakartidningen; 1979 Mar; 76(13):1185-8. PubMed ID: 431208 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]